Flow Space on MSN1d
5 Factors That Make It More Likely You'll Develop Heart Disease
Heart disease has long been considered a man's disease, but the reality is far more complex. Women face unique risks, ...
Chronic inflammation's connection to atrial fibrillation points to IL-1β as a promising treatment target
A recent Brazilian study published in Nature Cardiovascular Research has highlighted promising pathways for preventing and ...
Fierce Healthcare2d
How Eko Health is reinventing the stethoscope, aiming to change early detection of heart and lung disease
Eko Health has been advancing the use of artificial intelligence to help providers detect the early signs of disease, ...
Pharmabiz2d
Akura Medical begins patient enrollment in QUADRA-PE study of Katana Thrombectomy System to treat acute pulmonary embolism
Akura Medical begins patient enrollment in QUADRA-PE study of Katana Thrombectomy System to treat acute pulmonary embolism: Los Gatos, California Thursday, February 6, 2025, 18:00 ...
News Medical2d
COVID-19 speeds up artery plaque growth, raising heart disease risk
COVID-19 accelerates the progression of atherosclerotic plaques, increasing coronary inflammation and the risk of high-risk ...
Everyday Health2d
COVID-19 May Contribute to Clogged Arteries
A new study linked COVID-19 with the rapid growth of plaque in the coronary arteries. This plaque is a high-risk type prone ...
pulmonologyadvisor2d
Pulmonary Embolism With Cancer: Outpatient Management May Be Feasible
Outpatient management of patients with cancer-associated pulmonary embolism (PE) may be a feasible, safe approach with low short-term rates of recurrent venous thromboembolism (VTE), major bleeding, ...
Pulmonaryhypertensionnews.com2d
PAH treatment seralutinib shows benefits over nearly 1.5 years: Trial
In a trial, Gossamer Bio's PAH treatment candidate seralutinib reduced the resistance blood faces moving into the lungs over ...
Akura enrols first subject in pulmonary embolism trial of thrombectomy system
Failed to fetch dynamically imported module: https://finance.yahoo.com/assets/_app/immutable/nodes/105.JzBkOQ-g.js ...
DVLA lists every condition you need to declare or face £1,000 fine
It warns: "You need to tell DVLA about some medical conditions as they can affect your driving. You can be fined up to £1,000 ...
Endovascular Today3d
Akura Begins Pivotal Trial of Katana Thrombectomy System in Pulmonary Embolism
Akura Medical, Inc., a privately held portfolio company of Shifamed LLC that is developing treatments for venous thromboembolis ...
FIRST PATIENT ENROLLED IN AKURA MEDICAL'S US PIVOTAL TRIAL FOR PULMONARY EMBOLISM
Akura Medical, a Shifamed portfolio company focused on reshaping the landscape of venous thromboembolism (VTE) care, announced today the first patient enrollment in the QUADRA-PE study (NCT06672510) ...